A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers
Clinical trial NCT03411122 · COMPLETED
Trial details
- NCT number
- NCT03411122
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2018-01-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.